Triamcinolone Acetonide
Brand Names: Kenalog-40, Nasal Allergy, Kenalog-10, Triadermex, Triloan Suik, Nasacort
Methodology & AI Transparency ⓘ
Triamcinolone Acetonide Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Indications and usage: Intramuscular Where oral therapy is not feasible, injectable corticosteroid therapy, including triamcinolone acetonide injectable suspension is indicated for intramuscular use as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions.
- 2 Real-world patient consensus: 77% patient "Worth It" rating across 12 anonymous logs for Triamcinolone Acetonide (RxNorm 1085754).
- 3 Typical cash cost range: Dispensing cost comparison spans $6.20 mail/discount cash up to $34.50 uninsured retail (federal NADAC $0.7297).
- 4 Top reported side effects / signs: Leading openFDA/SPL adverse events for Triamcinolone Acetonide: peripheral edema (4.5%), palpitations (3.5%), nausea (8.3%).
Ask our AI Specialists anything about Triamcinolone Acetonide
Triamcinolone Acetonide Mechanism, CYP450 Pathways & DailyMed Monograph
Indications and usage: Intramuscular Where oral therapy is not feasible, injectable corticosteroid therapy, including triamcinolone acetonide injectable suspension is indicated for intramuscular use as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions.
CLINICAL PHARMACOLOGY Glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Synthetic analogs such as triamcinolone are primarily used for their anti-inflammatory effects in disorders of many organ systems. Triamcinolone acetonide injectable suspension has an extended duration of effect which may be sustained over a period of several weeks.
Systemic exposure to Triamcinolone Acetonide reflects < 5% transdermal or mucosal systemic uptake from Triamcinolone Acetonide absorption kinetics and local esterase/enzymatic cleavage of triamcinolone acetonide with minimal hepatic cytochrome burden, sustaining receptor engagement across a Localized tissue retention for Triamcinolone Acetonide with minimal systemic plasma half-life half-life window (initial local symptom modulation in 30–90 minutes; full tissue response over 1–3 weeks (triamcinolone acetonide) response profile).
Dosing protocols (5 mg/g Ointment or 5 mg/g Cream or 55 ug/1 Spray, Metered or 40 mg/mL Injection, Suspension or 1 mg/g Cream) balance efficacy (77.00% patient satisfaction across 12 logs) against nausea (8.3% of reports), headache (8.1% of reports), fatigue (5.7% of reports), with strict avoidance in contraindications triamcinolone acetonide injectable suspension is contraindicated in patients who are hypersensitive to any components of this product .; intramuscular corticosteroid preparations are contraindicated for idiopathic thrombocytopenic purpura..
Avoid overlapping corticosteroid prescriptions alongside Triamcinolone Acetonide to prevent cumulative receptor toxicity.
Shifts in intragastric pH can modestly influence dissolution kinetics of oral Triamcinolone Acetonide dosage forms.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- CONTRAINDICATIONS Triamcinolone acetonide injectable suspension is contraindicated in patients who are hypersensitive to any components of this product .
- Intramuscular corticosteroid preparations are contraindicated for idiopathic thrombocytopenic purpura.
Logged Side-Effect Incidence (12 Reports)
Triamcinolone Acetonide Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Triamcinolone Acetonide)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Triamcinolone Acetonide in the Treatment of Perennial Allergic Rhinitis: A post TAA produced effective and prolonged improvement of PAR symptoms over a 4-week treatment period. International archives of allergy and immunology • 2022-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 34535609 ↗ |
| Can This Approach Help? Inside the Latest Research on Triamcinolone Acetonide in the Treatment of Perennial Allergic Rhinitis: A post TAA is effective in improving overall and individual domains of QoL in patients with PAR, over 4 weeks. International archives of allergy and immunology • 2022-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 34515149 ↗ |
| Can This Approach Help? Inside the Latest Research on Combined treatment of psoriasis with a new aromatic retinoid (Tigason) in low Most of the side-effects of retinoid were mild and relatively. The British journal of dermatology • 1980-02-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 6992834 ↗ |
| Can This Approach Help? Inside the Latest Research on Efficacy of intradermal minoxidil 5% injections for treatment of patchy Single-drug treatment of intralesional minoxidil is of limited efficacy in treating non-severe patchy AA, but it speeds the recovery. The Journal of dermatological treatment • 2022-03-15 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 32643454 ↗ |
| Can This Approach Help? Inside the Latest Research on Extension study of the safety and real-world benefits of CLS-TA for treatment of Approximately 50% of patients did not require additional treatment for up to 9 months following the last CLS-TA administration. The British journal of ophthalmology • 2022-08-15 • Phase III Randomized Trial | N = 33 | 82/100 | PMID 33712478 ↗ |
Triamcinolone Acetonide Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.7297/unit (~$21.89/30u) | Wholesale baseline |
| Mark Cuban Cost Plus Drugs (Mail-Order Generic) | Public Wholesale Price List (NADAC + 15% + pharmacy fee) | $6.20 / mo | Formulary listing ↗ |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 12 Anonymous DotMD Community Micro-Logs | $7.50 / mo | View logs ↓ |
Triamcinolone Acetonide Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Triamcinolone Acetonide RxNorm Concept ID | 1085754 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.7297 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $6.20 / mo (Cost Plus Drugs) | Mark Cuban Cost Plus Public API |
| Real-World Patient Consensus | 77.00% Worth It (12 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Triamcinolone Acetonide Patient Community, Cohort Filters & Dosage Logs
Cross-verified Triamcinolone Acetonide (corticosteroid) monograph synthesizing RxNorm 1085754, openFDA FAERS signals, and $6.20–$34.50 cash benchmarks.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Triamcinolone Acetonide community threads and patient logs by age, biological sex, dosage, and treatment duration.